Impact of Medical–Pharmaceutical Separation Reform on Hospitalization Expenditure in Tertiary Public Hospitals: Difference-in-Difference Analysis Based on Panel Data from Beijing

References

• Cheng HC, Zhang YO, Sun J, et al. Impact of zero-mark-up medicines policy on hospital revenue structure: a panel data analysis of 136 public tertiary hospitals in China, 2012–2020. BMJ Glob Health. 2021;6(11):e007089. doi:10.1136/bmjgh-2021-007089
   PubMed Web of Science ®Google Scholar
• Du J, Xie J, Qian Y, et al. Impact of China’s zero mark-up drug policy on drug cost of NCDs’ outpatients: an interrupted time series analysis. BMC Health Serv Res. 2021;21(1):404. doi:10.1186/s12913-021-06414-3
   PubMed Web of Science ®Google Scholar
• Yan K, Yang C, Zhang H, et al. Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016-2018: an interrupted time series study in Shaanxi. BMJ Open. 2020;10(11):e037034. doi:10.1136/bmjopen-2020-037034
   PubMed Web of Science ®Google Scholar
• Wu Y, Han X, Qiu J. Impacts of the zero-markup drug policy on hospitalization expenses of patients with stroke in Western China: an interrupted time series analysis. Risk Manag Healthc Policy. 2024;17(null):777–788. doi:10.2147/RMHP.S456977
   PubMedGoogle Scholar
• Faraji M, Sharifi T, Mohammad-pour S, et al. Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model. Cost Eff Resour Allocation. 2024;22(1):15. doi:10.1186/s12962-024-00521-8
   PubMed Web of Science ®Google Scholar
• Selvaraj S, Farooqui HH, Karan A. Quantifying the financial burden of households’ out-of-pocket payments on medicines in India: a repeated cross-sectional analysis of National Sample Survey data, 1994–2014. BMJ Open. 2018;8(5):e018020. doi:10.1136/bmjopen-2017-018020
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Timofeyev Y, Ekkert NV, et al. The impact of health expenditures on public health in BRICS nations. J Sport Health Sci. 2019;8(6):516–519. doi:10.1016/j.jshs.2019.09.002
   PubMed Web of Science ®Google Scholar
• Sahoo PM, Rout HS, Jakovljevic M. Future health expenditure in the BRICS countries: a forecasting analysis for 2035. Globalization Health. 2023;19(1):49. doi:10.1186/s12992-023-00947-4
   PubMed Web of Science ®Google Scholar
• Nie X, Wang R, Liang G, et al. The impact of prescribing monitoring policy on drug use and expenditures in China: a multi-center interrupted time series study. Int J Health Policy. 2023;12(1):7343. doi:10.34172/ijhpm.2023.7343
   PubMed Web of Science ®Google Scholar
• Guo X, Xiao Y, Liu H, et al. Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis. Front Public Health. 2023;11:1079655. doi:10.3389/fpubh.2023.1079655
   PubMed Web of Science ®Google Scholar
• Mao W, Huang Y, Chen W. An analysis on rational use and affordability of medicine after the implementation of national essential medicines policy and zero mark-up policy in Hangzhou, China. PLoS One. 2019;14(3):e0213638. doi:10.1371/journal.pone.0213638
   PubMed Web of Science ®Google Scholar
• Yi H, Miller G, Zhang L, et al. Intended and unintended consequences of China’s Zero markup drug policy. Health Aff. 2015;34(8):1391–1398. doi:10.1377/hlthaff.2014.1114
   PubMed Web of Science ®Google Scholar
• Shi X, Zhu D, Man X, et al. The biggest reform to China’s health system”: did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals? Health Policy Plan. 2019;34(7):483–491. doi:10.1093/heapol/czz053
   PubMed Web of Science ®Google Scholar
• Aktas P. Physician perspectives on the implications of the diagnosis-related groups for medical practice in Turkey: a qualitative study. Int J Health Plann Manage. 2022;37(3):1769–1780. doi:10.1002/hpm.3445
   PubMed Web of Science ®Google Scholar
• Ni Z, Jia J, Cui L, et al. The Impact of China’s zero markup drug policy on hospitalization expenses for inpatients in tertiary public hospitals: evidence based on quantile difference-in-difference models. Healthcare. 2021;9(7):908. doi:10.3390/healthcare9070908
   Web of Science ®Google Scholar
• Quinn K. The 8 basic payment methods in health care. Ann Intern Med. 2015;163(4):300–+. doi:10.7326/m14-2784
   PubMed Web of Science ®Google Scholar
• Andoh-Adjei FX, Boudewijns B, Nsiah-Boateng E, et al. Effects of capitation payment on utilization and claims expenditure under National Health Insurance Scheme: a cross-sectional study of three regions in Ghana. Health Econ Rev. 2018;8:17. doi:10.1186/s13561-018-0203-9
   PubMed Web of Science ®Google Scholar
• Kirigia JM, Zere E, Akazili J. National health financing policy in Eritrea: a survey of preliminary considerations. BMC Int Health Hum Rights. 2012;12:16. doi:10.1186/1472-698x-12-16
   PubMed Web of Science ®Google Scholar
• Zhang GM, Zhang XY, Bilal M, et al. Identifying fraud in medical insurance based on blockchain and deep learning. Future Gener Comp Syst. 2022;130:140–154. doi:10.1016/j.future.2021.12.006
   Web of Science ®Google Scholar
• Sorensen MLK, Burau V. Why we need to move beyond diagnosis-related groups and how we might do so. J Health Serv Res Policy. 2016;21(1):64–66. doi:10.1177/1355819615586444
   PubMed Web of Science ®Google Scholar
• Zhang YH, Teng LB, Wang CY. Diagnosis-intervention packet-based Pareto chart of the proportion of high-cost cases and the analysis of the structure of hospitalization expenses. Technol Health Care. 2023;31(4):1355–1364. doi:10.3233/thc-220647
   PubMed Web of Science ®Google Scholar
• Ma WL, Qu J, Han H, et al. Statistical insight into China’s indigenous diagnosis-related-group system evolution. Healthcare. 2023;11(22):2965. doi:10.3390/healthcare11222965
   Web of Science ®Google Scholar
• Busse R, Geissler A, Aaviksoo A, et al. Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? BMJ-Brit Med J. 2013;346:f3197. doi:10.1136/bmj.f3197
   Web of Science ®Google Scholar
• Helbing C, Latta VB, Keene RE. Hospital outpatient services under Medicare, 1987. Health Care Financ Rev. 1990;11(4):147.
   PubMedGoogle Scholar
• Amatayakul M. DRG miscoding: error or intent? JAMA. 1993;269(7):867–868. doi:10.1001/jama.1993.03500070047018
   PubMed Web of Science ®Google Scholar
• Duckett SJ. Hospital payment arrangements to encourage efficiency: the case of Victoria, Australia. Health Policy. 1995;34(2):113–134. doi:10.1016/0168-8510(95)94014-Y
   PubMed Web of Science ®Google Scholar
• Dimitropoulos V, Yeend T, Zhou Q, et al. A new clinical complexity model for the Australian refined diagnosis related groups. Health Policy. 2019;123(11):1049–1052. doi:10.1016/j.healthpol.2019.08.012
   PubMed Web of Science ®Google Scholar
• Kim SJ, Han K-T, Kim SJ, et al. Impact of a diagnosis-related group payment system on cesarean section in Korea. Health Policy. 2016;120(6):596–603. doi:10.1016/j.healthpol.2016.04.018
   PubMed Web of Science ®Google Scholar
• Annear PL, Kwon S, Lorenzoni L, et al. Pathways to DRG-based hospital payment systems in Japan, Korea, and Thailand. Health Policy. 2018;122(7):707–713. doi:10.1016/j.healthpol.2018.04.013
   PubMed Web of Science ®Google Scholar
• Ishii M. DRG/PPS and DPC/PDPS as prospective payment systems. Japan Med Assoc J. 2012;55(4):279–291.
   PubMedGoogle Scholar
• Wang S, Wu N, Wang H, et al. Impacts of a new diagnosis‐related group point payment system on children’s medical services in China: length of stay and costs. Int J Health Plann Manage. 2023:1. doi:10.1002/hpm.3739
   Web of Science ®Google Scholar
• Lai Y, Fu H, Li L, et al. Hospital response to a case-based payment scheme under regional global budget: the case of Guangzhou in China. Soc Sci Med. 2022;292:114601. doi:10.1016/j.socscimed.2021.114601
   PubMed Web of Science ®Google Scholar
• Lu J, Lin Z, Xiong Y, et al. Performance assessment of medical service for organ transplant department based on diagnosis-related groups: a programme incorporating ischemia-free liver transplantation in China. Front Public Health. 2023;11:1092182. doi:10.3389/fpubh.2023.1092182
   PubMed Web of Science ®Google Scholar
• Wang J, Li P, Wen J. Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis. BMC Health Serv Res. 2020;20(1):519. doi:10.1186/s12913-020-05378-0
   PubMed Web of Science ®Google Scholar
• Li G, Chen D. Comparison of different extraction methods of active ingredients of Chinese medicine and natural products. J Sep Sci. 2024;47(1):2300712. doi:10.1002/jssc.202300712
   Web of Science ®Google Scholar
• Kondo A, Shigeoka H. Effects of universal health insurance on health care utilization, and supply-side responses: evidence from Japan. J Public Econ. 2013;99:1–23. doi:10.1016/j.jpubeco.2012.12.004
   Web of Science ®Google Scholar
• Koo JH, Jung HW. Which indicator should be used? A comparison between the incidence and intensity of catastrophic health expenditure: using difference-in-difference analysis. Health Econ Rev. 2022;12(1):1–10. doi:10.1186/s13561-022-00403-w
   PubMed Web of Science ®Google Scholar
• Quinones S, Mendola P, Tian L, et al. Ghana’s livelihood empowerment against poverty (1000) program seasonally impacts birthweight: a difference-in-differences analysis. Int J Public Health. 2023;68:1605336. doi:10.3389/ijph.2023.1605336
   PubMed Web of Science ®Google Scholar
• Liu STH, Lin H-M, Baine I, et al. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020;26(11):1708–+. doi:10.1038/s41591-020-1088-9
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55. doi:10.1093/biomet/70.1.41
   Web of Science ®Google Scholar
• Callaway B, Sant’Anna PH. Difference-in-differences with multiple time periods. J Econometrics. 2021;225(2):200–230. doi:10.1016/j.jeconom.2020.12.001
   Web of Science ®Google Scholar
• Olden A, Moen J. The triple difference estimator. Econometrics J. 2022;25(3):531–553. doi:10.1093/ectj/utac010
   Web of Science ®Google Scholar
• Goldfield N. The evolution of diagnosis-related groups (DRGs): from its beginnings in case-mix and resource use theory, to its implementation for payment and now for its current utilization for quality within and outside the hospital. Qual Manag Health Ca. 2010;19(1):3–16. doi:10.1097/QMH.0b013e3181ccbcc3
   PubMedGoogle Scholar
• Garber AM, Fuchs VR, Silverman JF. Case mix, costs, and outcomes: differences between faculty and community services in a university hospital. N Engl J Med. 1984;310(19):1231–1237. doi:10.1056/NEJM198405103101906
   PubMed Web of Science ®Google Scholar
• Kim TH, Park EC, Jang SI, et al. Effects of diagnosis-related group payment system on appendectomy outcomes. J Surg Res. 2016;206(2).
   Web of Science ®Google Scholar
• Osabohien R, Jaaffar AH, Akpa AF, et al. Mobile money, medical cost anxiety and welfare of individuals within the reproductive age in Malaysia. Humanit Soc Sci Commun. 2024;11(1):260. doi:10.1057/s41599-024-02767-2
   Google Scholar
• Kosaka M, Ozaki A, Kaneda Y, et al. Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd Cost Effectiven Res Alloc. 2023;21(1):35. doi:10.1186/s12962-023-00441-z
   PubMed Web of Science ®Google Scholar
• Jakovljevic MB, Nakazono S, Ogura S. Contemporary generic market in Japan – key conditions to successful evolution. Expert Rev Pharmacoecon Outcomes Res. 2014;14(2):181–194. doi:10.1586/14737167.2014.881254
   PubMed Web of Science ®Google Scholar
• Baker LC, Bundorf MK, Kessler DP. Vertical integration: hospital ownership of physician practices is associated with higher prices and spending. Health Aff. 2014;33(5):756–763. doi:10.1377/hlthaff.2013.1279
   Web of Science ®Google Scholar
• Hinrichs-Krapels S, Diehl J-C, Hunfeld N, et al. Towards sustainability for medical devices and consumables: the radical and incremental challenges in the technology ecosystem. J Health Serv Res Policy. 2022;27(4):253–254 13558196221110416. doi:10.1177/13558196221110416
   PubMed Web of Science ®Google Scholar
• Castro MC, Massuda A, Almeida G, et al. Brazil’s unified health system: the first 30 years and prospects for the future. Lancet. 2019;394(10195):345–356. doi:10.1016/S0140-6736(19)31243-7
   PubMed Web of Science ®Google Scholar
• Liu GG, Vortherms SA, Hong X. China’s health reform update. Annu Rev Public Health. 2017;38(2017):431–448. doi:10.1146/annurev-publhealth-031816-044247
   PubMedGoogle Scholar
• Van Minh H, Kim Phuong NT, Saksena P, et al. Financial burden of household out-of pocket health expenditure in Viet Nam: findings from the national living standard survey 2002–2010. Soc Sci Med. 2013;96:258–263. doi:10.1016/j.socscimed.2012.11.028
   PubMed Web of Science ®Google Scholar
• Wranik DW, Durier-Copp M. Physician remuneration methods for family physicians in Canada: expected outcomes and lessons learned. Health Care Anal. 2010;18(1):35–59. doi:10.1007/s10728-008-0105-9
   PubMed Web of Science ®Google Scholar
• Liu J, Capurro D, Nguyen A, et al. Early prediction of diagnostic-related groups and estimation of hospital cost by processing clinical notes. Npj Digit Med. 2021;4(1):103. doi:10.1038/s41746-021-00474-9
   PubMed Web of Science ®Google Scholar
• Waszyk-Nowaczyk M, Guzenda W, Kamasa K, et al. Cooperation between pharmacists and physicians - whether it was before and is it still ongoing during the pandemic? J Multidiscip Health. 2021;14:2101–2110. doi:10.2147/jmdh.S318480
   PubMed Web of Science ®Google Scholar
• Zhang LL, Sun LH. Impacts of diagnosis-related groups payment on the healthcare providers’ behavior in China: a cross-sectional study among physicians. Risk Manag Healthc Policy. 2021;14:2263–2276. doi:10.2147/rmhp.S308183
   PubMed Web of Science ®Google Scholar
• Bäuml M. How do hospitals respond to cross price incentives inherent in diagnosis-related groups systems? The importance of substitution in the market for sepsis conditions. Health Econ. 2021;30(4):711–728. doi:10.1002/hec.4215
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang G, Qin T-G, et al. Comparison of diagnosis-related groups (DRG)-based hospital payment system design and implementation strategies in different countries: the case of ischemic stroke. Biosci Trends. 2024;18(1):1–10. doi:10.5582/bst.2023.01027
   PubMedGoogle Scholar
• Souliotis K, Golna C, Tountas Y, et al. Informal payments in the Greek health sector amid the financial crisis: old habits die last. Eur J Health Econ. 2016;17(2):159–170. doi:10.1007/s10198-015-0666-0
   PubMed Web of Science ®Google Scholar
• Mv MK, Sastry NKB, Moonesar IA, et al. Predicting universal healthcare through health financial management for sustainable development in BRICS, GCC, and AUKUS economic blocks. Front Artif Intellig. 2022:5. doi:10.3389/frai.2022.887225
   Google Scholar
• Mathauer I, Wittenbecher F. Hospital payment systems based on diagnosis-related groups: experiences in low- and middle-income countries. Bullet World Health Organiz. 2013;91(10):746–756. doi:10.2471/blt.12.115931
   PubMed Web of Science ®Google Scholar
• Jolliffe D, Prydz EB. Societal poverty: a relative and relevant measure. World Bank Econ Rev. 2021;35(1):180–206. doi:10.1093/wber/lhz018
   Web of Science ®Google Scholar
• Cheng J, Wen C, Jiang S, et al. Construction and application of SPD automated management module for interventional high-value consumables based on RFID sensors. J Sens. 2022;2022:2184694. doi:10.1155/2022/2184694
   Web of Science ®Google Scholar
• Ronco V, Dilecce M, Lanati E, et al. Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations? J Pharm Policy Pract. 2021;14(1):1–11. doi:10.1186/s40545-021-00311-0
   PubMedGoogle Scholar
• Deilkas ET, Rosta J, Baathe F, et al. Physician participation in quality improvement work- interest and opportunity: a cross-sectional survey. BMC Primary Care. 2022;23(1):267. doi:10.1186/s12875-022-01878-6
   PubMedGoogle Scholar
• Carrillo PE, Castro E, Scartascini C. Public good provision and property tax compliance: evidence from a natural experiment q. J Public Econ. 2021;198:104422. doi:10.1016/j.jpubeco.2021.104422
   Web of Science ®Google Scholar
• Ma Y, Wang W. Original The impact of diagnosis related group payment on the performance of public hospitals. Am J Transl Res. 2021;13(6):6796–6801.
   PubMed Web of Science ®Google Scholar
• Zhi MJ, Hu LL, Geng FL, et al. Analysis of the cost and case-mix of post-acute stroke patients in China using quantile regression and the decision-tree models. Risk Manag Healthc Policy. 2022;15:1113–1127. doi:10.2147/rmhp.S361385
   PubMed Web of Science ®Google Scholar